Clinical Trial Update: Gefitinib in Treating Patients With Locally Advanced Esophageal Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating gefitinib for locally advanced esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• Iressa (gefitinib)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Esophageal Cancer | Phase 2 | Status: COMPLETED